Development of mammalian serum albumin affinity purification media by peptide phage display.
about
Phage display of random peptide libraries: applications, limits, and potential.Characterization of the low molecular weight human serum proteome.Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn.Chromato-panning: an efficient new mode of identifying suitable ligands from phage display libraries.High throughput profiling of serum phosphoproteins/peptides using the SELDI-TOF-MS platformFibrin specific peptides derived by phage display: characterization of peptides and conjugates for imagingProteomics: challenges, techniques and possibilities to overcome biological sample complexityDesign of peptide affinity ligands for S-protein: a comparison of combinatorial and de novo design strategies.Ebselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal cancer cell linesCleaning-in-place of immunoaffinity resins monitored by in situ ATR-FTIR spectroscopy.Plasma proteomic profile of sulfur mustard exposed lung diseases patients using 2-dimensional gel electrophoresis.Investigation of the efficacy of albumin removal procedures on porcine serum proteome profile.Plasma fractionation enriches post-myocardial infarction samples prior to proteomics analysis.Evaluation of in situ albumin binding surfaces: a study of protein adsorption and platelet adhesion.Proteomic analysis of the cardiac extracellular matrix: clinical research applications.Dye attached poly(hydroxyethyl methacrylate) cryogel for albumin depletion from human serum.Effective depletion of albumin using a new peptide-based affinity medium.
P2860
Q31039269-E19248F5-53EE-4F78-90B4-0B7E4C67C73BQ31153810-EC6DDA93-17AC-487F-9F50-D25BA5D05DFCQ33319667-689E7205-07B1-40BE-BCA1-7C4EA646F272Q33418927-379F8363-A62B-410F-935D-AF3D6326E63EQ34074494-46C1A89D-7D9C-4A82-B56F-7F376A401EE8Q34134243-C5FE6845-57C6-42DD-BEFC-BDEE8BEF1E76Q34177041-58EA05EF-A640-49D6-9F5A-62DEF638D3A1Q34637357-91C2AC78-7786-4929-BA9C-BE177286F625Q35687202-0D4C45D1-BE66-4186-8CC7-EFE83BFDBF94Q36001508-518C6048-E1EE-41CE-A555-82D607A58CE1Q38310935-01467873-F1A9-4D96-B310-C02DF5F4B88CQ40894315-03FB7E97-746A-453F-9218-2E16377042D7Q42218705-37431668-A436-457A-B0D1-1E31A3DD9F86Q44222702-90216CCD-C042-4E68-B61E-B63FF7F38DD2Q47246912-2CBCA932-98F4-42A3-B58E-2C091D70AA90Q50247668-F87827BF-7E1B-457F-AD83-0A324A3FCFFBQ50485649-476E57B6-430B-4AAE-9A1C-C156A035F18C
P2860
Development of mammalian serum albumin affinity purification media by peptide phage display.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Development of mammalian serum ...... edia by peptide phage display.
@ast
Development of mammalian serum ...... edia by peptide phage display.
@en
type
label
Development of mammalian serum ...... edia by peptide phage display.
@ast
Development of mammalian serum ...... edia by peptide phage display.
@en
prefLabel
Development of mammalian serum ...... edia by peptide phage display.
@ast
Development of mammalian serum ...... edia by peptide phage display.
@en
P2093
P356
P1476
Development of mammalian serum ...... edia by peptide phage display.
@en
P2093
Aaron K Sato
Arthur C Ley
Charles R Wescott
Daniel B DeOliveira
Edward H Cohen
Greg P Conley
Jasmin Enright
Lee A Morganelli
Mary Devlin
Qi Long Wu
P304
P356
10.1021/BP010181O
P577
2002-03-01T00:00:00Z